Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Head and Neck Cancer

Free Subscription Articles published in Thyroid Retrieve available abstracts of 193 articles: HTML format

Single Articles

November 2025
1. VAN DE BERG DJ, Vriens MR, van Santen HM, Seur A, et al
   Core Outcome Set of the Surgical Treatment of Differentiated Thyroid Carcinoma: International Consensus by Delphi Study.
   Thyroid. 2025 Nov 7. doi: 10.1177/10507256251390871.
   PubMed     Abstract available
   
   
   
2. SCHONEBAUM LE, Oudijk L, Stegenga MT, Bramer WM, et al
   The Prognostic Value of Immunohistochemical Biomarkers in Medullary Thyroid Carcinoma: A Systematic Review and Meta-Analysis.
   Thyroid. 2025 Nov 6. doi: 10.1177/10507256251393208.
   PubMed     Abstract available
   
   
   
3. RUSSELL M, Wu CW, Huang TY, Tuttle RM, et al
   Scholarly Dialogue on Risk to the Recurrent Laryngeal Nerve with Thermal Ablation Procedures: A Reflection on Empirical Practices.
   Thyroid. 2025;35:1221-1229.
   PubMed     Abstract available
   
   
   October 2025
4. PORCELLI T, Moog S, Bani MA, Hadoux J, et al
   Validation of the International Medullary Thyroid Carcinoma Grading System in Patients with Distant Metastases.
   Thyroid. 2025 Oct 28. doi: 10.1177/10507256251388028.
   PubMed     Abstract available
   
   
   
5. ALZAHRANI AS, Alsaihati B, Benito A, Alghamdi B, et al
   Germline Telomere-Regulating Gene Variants Are Not Associated with Thyroid Cancer in a Saudi Arabian Population.
   Thyroid. 2025 Oct 28. doi: 10.1177/10507256251388092.
   PubMed     Abstract available
   
   
   
6. PRAW SS, Gigliotti BJ, Tessnow A, Kang H, et al
   Executive Summary of the 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer.
   Thyroid. 2025 Oct 24. doi: 10.1177/10507256251390877.
   PubMed     Abstract available
   
   
   
7. LINDSAY CV, Wang F, Thomas SM, Frieze T, et al
   Prognostic Thresholds for Lymph Node Metastasis in Medullary Thyroid Cancer: A Restricted Cubic Splines Analysis.
   Thyroid. 2025 Oct 20. doi: 10.1177/10507256251388406.
   PubMed     Abstract available
   
   
   
8. KIM HI, Shin JH, Kim B, Jin M, et al
   The Association of Number of Retrieved Lymph Nodes with Oncologic Outcomes in Patients with Papillary Thyroid Cancer with Lateral Cervical Nodal Metastasis.
   Thyroid. 2025 Oct 15. doi: 10.1177/10507256251388093.
   PubMed     Abstract available
   
   
   September 2025
9. LEE S, Kim SJ, Choi JY, Park N, et al
   Comparative Study of Clinical Outcomes for Total Thyroidectomy/Lobectomy and Isthmusectomy in Patients with Isthmic Papillary Thyroid Carcinoma.
   Thyroid. 2025 Sep 29. doi: 10.1177/10507256251382600.
   PubMed     Abstract available
   
   
   
10. CHEN T, Li X, Hong D, Yin L, et al
    Targeting B7-H3 in Cancer-Associated Fibroblasts Using Nanosystems Suppresses Anaplastic Thyroid Carcinoma Progression.
    Thyroid. 2025 Sep 3. doi: 10.1177/10507256251372644.
    PubMed     Abstract available
    
    
    
11. ZHANG J, Castroneves LA, Lindsey SC, Han R, et al
    Do Prognostic Differences Exist Among High-Risk RET Mutations? A Comparison of Outcomes Between the RET C634R and Other C634 Mutations in Hereditary Medullary Thyroid Carcinoma.
    Thyroid. 2025 Sep 3. doi: 10.1177/10507256251372196.
    PubMed     Abstract available
    
    
    
12. KINI S, Yildiz V, Mitchell D, Gogineni E, et al
    Immunotherapy in Initial Treatment of Anaplastic Thyroid Cancer: Evaluation of Overall Survival in a National Cancer Database Study.
    Thyroid. 2025 Sep 3. doi: 10.1177/10507256251372191.
    PubMed     Abstract available
    
    
    August 2025
13. TRIMBOLI P, Papini E, Bojunga J, Camponovo C, et al
    Interobserver Agreement Among Thyroid Ultrasound Operators in Defining Thyroid Nodules as Subcapsular.
    Thyroid. 2025 Aug 25. doi: 10.1177/10507256251372649.
    PubMed     Abstract available
    
    
    
14. SPIEZIA S, Offi C, Misso C, Antonelli G, et al
    First-in-Human Clinical Feasibility Study of Ablation of Benign Thyroid Nodules Using Nanosecond Pulsed Field Ablation.
    Thyroid. 2025 Aug 21. doi: 10.1177/10507256251372166.
    PubMed     Abstract available
    
    
    
15. CALCATERRA M, Sada A, Karslioglu-French E, Morariu EM, et al
    Disease-Specific and Histological Outcomes of Preoperative TERT Promoter Mutation Detected in Isolation or in Combination with Other Mutations in Thyroid Neoplasms.
    Thyroid. 2025 Aug 20. doi: 10.1177/10507256251370304.
    PubMed     Abstract available
    
    
    
16. ELISEI R, Wirth LJ, Capdevila J, Hoff AO, et al
    Patient-Reported Tolerability of Selpercatinib Compared to Cabozantinib/Vandetanib: A Secondary Analysis of the LIBRETTO-531 Randomized-Controlled Trial in RET-Mutant Medullary Thyroid Cancer.
    Thyroid. 2025 Aug 18. doi: 10.1177/10507256251367352.
    PubMed     Abstract available
    
    
    
17. BAUZON J, Ponce de Leon-Ballesteros G, Lincango E, Medina-Franco H, et al
    Neoadjuvant Therapy with Multikinase Inhibitors for Locally Advanced Differentiated Thyroid Cancer: A Systematic Review.
    Thyroid. 2025 Aug 13. doi: 10.1177/10507256251367286.
    PubMed     Abstract available
    
    
    
18. ITO Y, Miyauchi A, Yamamoto M, Kihara M, et al
    Dynamic Risk Assessment Using Unstimulated Serum Thyroglobulin Level and Thyroglobulin Doubling Rate after Total Thyroidectomy for Papillary Thyroid Carcinoma.
    Thyroid. 2025 Aug 11. doi: 10.1177/10507256251367242.
    PubMed     Abstract available
    
    
    
19. RINGEL MD, Sosa JA, Baloch Z, Bischoff L, et al
    2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer.
    Thyroid. 2025;35:841-985.
    PubMed     Abstract available
    
    
    July 2025
20. DE LEO S, Bottici V, Pellegriti G, Russo M, et al
    Clinical and Pathological Factors Associated with Disease Persistence in Pediatric Patients with Differentiated Thyroid Carcinoma.
    Thyroid. 2025 Jul 30. doi: 10.1177/10507256251363978.
    PubMed     Abstract available
    
    
    
21. TOLOZA FJK, Gubbi S, Klubo-Gwiezdzinska J
    Trends in Survival and Factors Associated with Survival in Primary Thyroid Lymphoma: A SEER-Based Analysis (1975-2021).
    Thyroid. 2025 Jul 30. doi: 10.1177/10507256251363141.
    PubMed     Abstract available
    
    
    
22. ALZUMAILI BA, Instrum R, Alabkaa A, Sadow PM, et al
    Pathological Diagnosis of Thyroid Nodules with Preoperatively Detected TERT Promoter Mutations in the Absence of BRAF(V600E): A Bi-Center Series of 52 Cases.
    Thyroid. 2025 Jul 28. doi: 10.1177/10507256251363450.
    PubMed     Abstract available
    
    
    
23. O'NEILL CJ, Rowe CW, Morris-Baguley H, Carlson MA, et al
    Thyroid Cancer Survivors Experience Persistent Symptoms and Health-Related Quality-of-Life Deficits 12 Months Following Surgery.
    Thyroid. 2025 Jul 10. doi: 10.1089/thy.2025.0149.
    PubMed     Abstract available
    
    
    
24. MARION I, Schulz S, Glasner C, Kather JN, et al
    Deep Learning Discovers New Morphological Features while Predicting Genetic Alterations from Histopathology of Papillary Thyroid Carcinoma.
    Thyroid. 2025 Jul 3. doi: 10.1089/thy.2024.0691.
    PubMed     Abstract available
    
    
    
25. CABANILLAS ME, Busaidy NL, Gunn GB, Iyer PC, et al
    Adjuvant Pembrolizumab after Upfront Multimodal Therapy for Stage IVB Anaplastic Thyroid Cancer.
    Thyroid. 2025 Jul 3. doi: 10.1089/thy.2025.0194.
    PubMed     Abstract available
    
    
    
26. LIM H, Cho SJ, Jeong Y, Jeong SY, et al
    Efficacy and Safety of Thermal Ablation for Indeterminate Thyroid Nodules: A Systematic Review of the Literature and Meta-Analysis.
    Thyroid. 2025;35:748-762.
    PubMed     Abstract available
    
    
    
27. VAID S, Chuki E, Veeraraghavan P, Jedlinski-Obrzut M, et al
    Thyroid Carcinoma in Birt-Hogg-Dube Syndrome: Case Series and Review of Literature.
    Thyroid. 2025;35:828-835.
    PubMed     Abstract available
    
    
    June 2025
28. SCHONEBAUM LE, van den Berg SAA, van Balkum M, Visser WE, et al
    Progastrin-Releasing Peptide and Procalcitonin as Additional Markers in the Diagnostic Workup for Medullary Thyroid Carcinoma.
    Thyroid. 2025 Jun 27. doi: 10.1089/thy.2024.0293.
    PubMed     Abstract available
    
    
    
29. ONAGA R, Enokida T, Tanaka N, Hoshi Y, et al
    Long-Term Clinical Outcomes of Patients with Differentiated Thyroid Cancer Treated with Lenvatinib: Results from Real-World Practice in Japan.
    Thyroid. 2025 Jun 9. doi: 10.1089/thy.2025.0040.
    PubMed     Abstract available
    
    
    
30. HA EJ, Lee JH, Mak N, Duh AK, et al
    A Deep Learning-Based Artificial Intelligence Model Assisting Thyroid Nodule Diagnosis and Management: Pilot Results for Evaluating Thyroid Malignancy in Pediatric Cohorts.
    Thyroid. 2025 Jun 2. doi: 10.1089/thy.2024.0627.
    PubMed     Abstract available
    
    
    
31. CHOI J, Sherman E, Dee EC, Treechairusame T, et al
    Long-Term Results of External Beam Radiation Therapy with or Without Concurrent Chemotherapy in Differentiated Thyroid Cancer.
    Thyroid. 2025;35:633-641.
    PubMed     Abstract available
    
    
    May 2025
32. RUAN X, Yang F, Li M, Dong Q, et al
    Multi-Omics-Based Characterization of DNA Methylation Episignatures for Papillary Thyroid Cancer in a Chinese Population.
    Thyroid. 2025 May 30. doi: 10.1089/thy.2024.0611.
    PubMed     Abstract available
    
    
    
33. LAI F, Chen W, Zhang J, Chen W, et al
    Reproductive Concern, Fertility Intention, and Pregnancy Outcomes in Young Women with Thyroid Cancer after Thyroid Surgery: A Prospective Cohort Study.
    Thyroid. 2025 May 22. doi: 10.1089/thy.2024.0660.
    PubMed     Abstract available
    
    
    
34. LIU W, Dong Z, Cao W, Jin H, et al
    The Natural Course of Low-Risk Papillary Thyroid Microcarcinoma During Pregnancy: A Prospective Active Surveillance Study.
    Thyroid. 2025 May 22. doi: 10.1089/thy.2024.0702.
    PubMed     Abstract available
    
    
    
35. ROBERTS TJ, Wirth LJ
    Management of Adverse Events During Treatment for Advanced Thyroid Cancer.
    Thyroid. 2025 May 22. doi: 10.1089/thy.2024.0755.
    PubMed     Abstract available
    
    
    
36. CHUKI E, Behairy N, Auh S, Makarewicz A, et al
    Comparison of Progression-Free Survival in Familial Non-Medullary Thyroid Cancer and Sporadic Differentiated Thyroid Cancer Patients.
    Thyroid. 2025 May 20. doi: 10.1089/thy.2024.0588.
    PubMed     Abstract available
    
    
    
37. BISCHOFF H, Fattori A, Moinard-Butot F, Schneegans O, et al
    First Report of SPECC1L::ALK Fusion in Medullary Thyroid Carcinoma with Remarkable Response to Alectinib.
    Thyroid. 2025 May 16. doi: 10.1089/thy.2025.0017.
    PubMed     Abstract available
    
    
    
38. ZHANG Y, Shi X, Cheng S, Liu J, et al
    Long Noncoding RNAs Papillary Thyroid Carcinoma Susceptibility Candidate 3 Antisense 1 and Papillary Thyroid Carcinoma Susceptibility Candidate 3 Synergistically Regulate ZC3H12A mRNA Stability via Vimentin at 14q13.3 Thyroid Cancer Locus.
    Thyroid. 2025 May 16. doi: 10.1089/thy.2024.0674.
    PubMed     Abstract available
    
    
    
39. CABANILLAS ME, Akhave N, Banuchi V, Busaidy N, et al
    Reimagining the Therapeutic Approach for Anaplastic Thyroid Cancer: The Roadmap to a Cure.
    Thyroid. 2025;35:462-470.
    PubMed     Abstract available
    
    
    April 2025
40. LIU S, Lu C, Li Y, Zhu L, et al
    Residential Greenness Is Associated with Lower Thyroid Nodule Prevalence: A Nationwide Study in China.
    Thyroid. 2025 Apr 23. doi: 10.1089/thy.2024.0616.
    PubMed     Abstract available
    
    
    
41. CHEN J, Zhong J, Zhuang Y, Deng B, et al
    Multimodality Ultrasound Utilizing Microvascular Flow Imaging and Shear Wave Elastography to Guide Fine-Needle Aspiration of Thyroid Lesions: A Prospective Study Validating Pattern-Based Microvascular Classification.
    Thyroid. 2025 Apr 21. doi: 10.1089/thy.2024.0586.
    PubMed     Abstract available
    
    
    
42. ATHREYA S, Melehy A, Suthahar SSA, Ivezic V, et al
    Combining Ultrasound Imaging and Molecular Testing in a Multimodal Deep Learning Model for Risk Stratification of Indeterminate Thyroid Nodules.
    Thyroid. 2025 Apr 21. doi: 10.1089/thy.2024.0584.
    PubMed    
    
    
    March 2025
43. KIM BC, Pak SJ, Kwon D, Kim WW, et al
    Clinically Significant Central Lymph Node Metastasis is Not Common in Patients with Clinically N0 Papillary Thyroid Carcinoma on Both Ultrasonography and CT.
    Thyroid. 2025 Mar 31. doi: 10.1089/thy.2024.0484.
    PubMed     Abstract available
    
    
    
44. PARK SH, Sugier PE, Asgari Y, Karimi M, et al
    Reproductive Factors, Sex Hormone Levels, and Differentiated Thyroid Cancer Risk: A Mendelian Randomization Study.
    Thyroid. 2025 Mar 26. doi: 10.1089/thy.2024.0548.
    PubMed     Abstract available
    
    
    
45. EINSPIELER H, Hennig B, Reiterits B, Klimpfinger H, et al
    A Retrospective Case-Control Study Examining the Association of Thyroid-Stimulating Hormone Suppression and Vascular Wall Inflammation on [(18)F]FDG-PET/CT.
    Thyroid. 2025 Mar 7. doi: 10.1089/thy.2024.0476.
    PubMed     Abstract available
    
    
    
46. RODRIGUEZ-LLOVERAS H, Zafon C, Iglesias C, Marcos-Ruiz J, et al
    DNA Methylation Dynamics and Prognostic Implications in Metastatic Differentiated Thyroid Cancer.
    Thyroid. 2025 Mar 6. doi: 10.1089/thy.2024.0303.
    PubMed     Abstract available
    
    
    
47. WU J, Stewardson P, Eszlinger M, Khalil M, et al
    Development of a Nomogram to Integrate Molecular Testing and Clinical Variables to Improve Malignancy Risk Assessment Among Cytologically Indeterminate Thyroid Nodules.
    Thyroid. 2025 Mar 5. doi: 10.1089/thy.2024.0481.
    PubMed     Abstract available
    
    
    February 2025
48. BELL C, White SL, Tylee T, Dighe M, et al
    Thyroid Nodule Sphericity Metrics Discriminate Benign and Malignant Follicular and Oncocytic Neoplasms.
    Thyroid. 2025 Feb 25. doi: 10.1089/thy.2024.0670.
    PubMed     Abstract available
    
    
    
49. ZHU Q, Liu J, Hu J, Zhang Y, et al
    The Epidemiological Landscape of Thyroid Cancer and Estimates of Overdiagnosis in China: A Population-Based Study.
    Thyroid. 2025 Feb 19. doi: 10.1089/thy.2024.0583.
    PubMed     Abstract available
    
    
    
50. VALERO C, Eagan A, Adilbay D, Matsuura D, et al
    A Clinical Nomogram to Predict Survival Outcomes in Patients with Well-Differentiated Thyroid Cancer.
    Thyroid. 2025 Feb 14. doi: 10.1089/thy.2024.0486.
    PubMed     Abstract available
    
    
    
51. KOTHARI R, Donner JR, Balakrishnan K, Hartman G, et al
    Composition and Priorities of Multidisciplinary Pediatric Thyroid Programs: A Consensus Statement.
    Thyroid. 2025 Feb 14. doi: 10.1089/thy.2024.0496.
    PubMed     Abstract available
    
    
    
52. PRETE A, Torregrossa L, Gambale C, Ciampi R, et al
    The Usefulness of the International Grading System in the Management of Sporadic Medullary Thyroid Carcinoma.
    Thyroid. 2025 Feb 11. doi: 10.1089/thy.2024.0444.
    PubMed     Abstract available
    
    
    January 2025
53. RAO S, Frates MC, Benson CB, Cherella CE, et al
    Utility of Ultrasound Surveillance for Thyroid Cancer in Children.
    Thyroid. 2025 Jan 31. doi: 10.1089/thy.2024.0624.
    PubMed     Abstract available
    
    
    
54. NACHUM S, Tondi Resta I, Baloch Z, Mandel SJ, et al
    Thyroid Nodules with Indeterminate Cytology and Negative Molecular Profile: Prevalence of Malignancy and Practice Paradigms for Surveillance.
    Thyroid. 2025 Jan 28. doi: 10.1089/thy.2024.0455.
    PubMed     Abstract available
    
    
    
55. BALLAL S, Yadav MP, Satapathy S, Roesch F, et al
    Long-Term Outcomes in Radioiodine-Resistant Follicular Cell-Derived Thyroid Cancers Treated with [(177)Lu]Lu-DOTAGA.FAPi Dimer Therapy.
    Thyroid. 2025 Jan 27. doi: 10.1089/thy.2024.0229.
    PubMed     Abstract available
    
    
    
56. KHAN E, Hylton H, Rajan N, Bouley SJ, et al
    Proteomic Profiling of Medullary Thyroid Cancer Identifies CAPN1 as a Key Regulator of NF1 and RET Fueled Growth.
    Thyroid. 2025 Jan 27. doi: 10.1089/thy.2024.0102.
    PubMed     Abstract available
    
    
    
57. JEONG SY, Baek SM, Shin S, Son JM, et al
    Radiofrequency Ablation of Low-Risk Papillary Thyroid Microcarcinoma: A Retrospective Cohort Study Including Patients with More than 10 Years of Follow-up.
    Thyroid. 2025 Jan 27. doi: 10.1089/thy.2024.0535.
    PubMed     Abstract available
    
    
    
58. BYUN H, Lee HS, Song YS, Park YJ, et al
    Transcriptome of Anaplastic Thyroid Cancer Reveals Two Molecular Subtypes with Distinct Tumor Microenvironment and Prognosis.
    Thyroid. 2025 Jan 27. doi: 10.1089/thy.2024.0266.
    PubMed     Abstract available
    
    
    
59. PAPACHRISTOS A, Zhou L, Sheen A, Sywak M, et al
    Tumor-Infiltrating Lymphocytes Assessed Using the International TILs Working Group System Are Not Prognostic in Medullary Thyroid Cancer.
    Thyroid. 2025 Jan 27. doi: 10.1089/thy.2024.0595.
    PubMed     Abstract available
    
    
    
60. FUNG MHM, Tang C, Kwok GW, Chan TH, et al
    High Rates of Unnecessary Surgery for Indeterminate Thyroid Nodules in the Absence of Molecular Test and the Cost-Effectiveness of Utilizing Molecular Test in an Asian Population: A Decision Analysis.
    Thyroid. 2025 Jan 21. doi: 10.1089/thy.2024.0436.
    PubMed     Abstract available
    
    
    
61. BAXTER SM, Lund LC, Andersen JH, Brix TH, et al
    Glucagon-Like Peptide 1 Receptor Agonists and Risk of Thyroid Cancer: An International Multisite Cohort Study.
    Thyroid. 2025 Jan 8. doi: 10.1089/thy.2024.0387.
    PubMed     Abstract available
    
    
    
62. SCHOLFIELD DW, Xu B, Levyn H, Eagan A, et al
    High-Grade Follicular Cell-Derived Non-Anaplastic Thyroid Carcinoma: Correlating Extent of Invasion and Mutation Profile with Oncologic Outcome.
    Thyroid. 2025 Jan 6. doi: 10.1089/thy.2024.0499.
    PubMed     Abstract available
    
    
    December 2024
63. QIANG JK, Sutradhar R, Everett K, Eskander A, et al
    Association Between Serum Thyrotropin and Cancer Recurrence in Differentiated Thyroid Cancer: A Population-Based Retrospective Cohort Study.
    Thyroid. 2024 Dec 26. doi: 10.1089/thy.2024.0330.
    PubMed     Abstract available
    
    
    
64. JAGER EC, Metman MJH, Timmenga IAC, Zandee WT, et al
    Trends in the Incidence, Organization of Care, and Surgical Treatment of Medullary Thyroid Cancer: A Population-Based Study.
    Thyroid. 2024 Dec 20. doi: 10.1089/thy.2024.0433.
    PubMed     Abstract available
    
    
    
65. KUNSTREICH M, Ronckers CM, Lorenz K, Wolf SH, et al
    Subsequent Thyroid Carcinomas in Children and Adolescents Registered in the German MET Consortium (1997-2023).
    Thyroid. 2024 Dec 19. doi: 10.1089/thy.2024.0312.
    PubMed     Abstract available
    
    
    
66. DUENAS JP, Buitrago-Gomez N, Rahal A, Steck JH, et al
    Radiofrequency Ablation for Solitary Autonomously Functioning Thyroid Nodules: Multicenter Study from Latin America.
    Thyroid. 2024 Dec 19. doi: 10.1089/thy.2024.0338.
    PubMed     Abstract available
    
    
    
67. MOON SY, Son M, Cho JH, Kim HI, et al
    Association Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Thyroid Cancer.
    Thyroid. 2024 Dec 18. doi: 10.1089/thy.2024.0522.
    PubMed     Abstract available
    
    
    
68. ERDOGAN MF, Bahcecioglu AB, Avci Merdin F, Elhan AH, et al
    Changes in the Volume and Diameter of Benign Thyroid Nodules: A 10-Year Follow-Up Study.
    Thyroid. 2024 Dec 18. doi: 10.1089/thy.2024.0405.
    PubMed     Abstract available
    
    
    
69. MOON HH, Baek JH, Chung SR, Choi YJ, et al
    Preliminary Report Examining Efficacy and Safety of Radiofrequency Ablation for the Treatment of Skin-Involving Recurrent Thyroid Cancer.
    Thyroid. 2024 Dec 17. doi: 10.1089/thy.2024.0339.
    PubMed     Abstract available
    
    
    
70. HU G, Xue J, Yu J, Dou Q, et al
    High Prevalence of TBC1D12 5'UTR Mutations in Anaplastic Thyroid Cancer.
    Thyroid. 2024 Dec 16. doi: 10.1089/thy.2024.0345.
    PubMed     Abstract available
    
    
    
71. HAMIDI S, Yedururi S, Hu MI, Busaidy NL, et al
    Efficacy and Safety of Selective RET Inhibitors in Patients with Advanced Hereditary Medullary Thyroid Carcinoma.
    Thyroid. 2024 Dec 4. doi: 10.1089/thy.2024.0495.
    PubMed     Abstract available
    
    
    
72. JIN X, Broome DT, Lew M, Heider A, et al
    Performance of Afirma Genomic Sequencing Classifier in Binary Subcategories of Atypia of Undetermined Significance Thyroid Nodules: Single Versus Repeat Diagnosis.
    Thyroid. 2024 Dec 4. doi: 10.1089/thy.2024.0277.
    PubMed     Abstract available
    
    
    November 2024
73. FERNANDES-TAYLOR S, Bowles EJA, Venkatesh M, Doud R, et al
    Differential Ultrasound Rates Mirror Sex Disparities in Thyroid Cancer.
    Thyroid. 2024 Nov 28. doi: 10.1089/thy.2024.0344.
    PubMed     Abstract available
    
    
    
74. KUO TC, Chen KY, Hu HW, Jhuang JY, et al
    Surgical and Pathological Challenges in Thyroidectomy after Thermal Ablation of Thyroid Nodules.
    Thyroid. 2024 Nov 22. doi: 10.1089/thy.2024.0281.
    PubMed     Abstract available
    
    
    
75. VOHRA V, Yesantharao LV, Stemme R, Seal SM, et al
    Association Between Environmental Air Pollution and Thyroid Cancer and Nodules: A Systematic Review.
    Thyroid. 2024 Nov 18. doi: 10.1089/thy.2024.0317.
    PubMed     Abstract available
    
    
    
76. HUSTON-PATERSON HH, Mao YV, Tseng CH, Kim J, et al
    The Relationship Between Hospital Safety-Net Burden on Outcomes for High-Volume Thyroid Cancer Surgeons.
    Thyroid. 2024 Nov 11. doi: 10.1089/thy.2024.0268.
    PubMed     Abstract available
    
    
    
77. JASIM S, Golding A, Bimston D, Alshalalfa M, et al
    Cytologic and Molecular Assessment of Isthmus Thyroid Nodules and Carcinomas.
    Thyroid. 2024 Nov 11. doi: 10.1089/thy.2024.0254.
    PubMed     Abstract available
    
    
    October 2024
78. NGUYEN TNA, Nguyen VPT, Kurohama H, Akazawa Y, et al
    Association Between Gross Features and Coexistence of BRAF(V600E) and TERT Promoter Mutations in Papillary Thyroid Carcinomas: A Combined Analysis Incorporating Clinicopathologic Features.
    Thyroid. 2024 Oct 31. doi: 10.1089/thy.2024.0310.
    PubMed     Abstract available
    
    
    
79. KUHLEN M, Wellbrock M, Kunstreich M, Trubenbach C, et al
    Incidence and Temporal Patterns of Differentiated Thyroid Carcinoma in Children and Adolescents in Germany: A Pooled Analysis Based on Data from the German Malignant Endocrine Tumor Registry and the German Childhood Cancer Registry.
    Thyroid. 2024 Oct 30. doi: 10.1089/thy.2024.0534.
    PubMed     Abstract available
    
    
    
80. PILZ MJ, Seyringer S, Singer S, Ioannidis G, et al
    The Cancer-Specific Health Economic Measure QLU-C10D is Valid and Responsive for Assessing Health Utility in Patients with Thyroid Cancer.
    Thyroid. 2024 Oct 30. doi: 10.1089/thy.2024.0396.
    PubMed     Abstract available
    
    
    
81. GU X, Zhu P, Zhang H, Wang W, et al
    A Qualitative Thematic Analysis Exploring Chinese Young Adults' Experiences in Decision Making on the Management of Low-Risk Papillary Thyroid Cancer.
    Thyroid. 2024 Oct 17. doi: 10.1089/thy.2024.0210.
    PubMed     Abstract available
    
    
    
82. ELDEIRY LS, Lawrence JE, Taneja C, Margulies D, et al
    American Thyroid Association Policy Statement: Impact of Changes in Fine Needle Aspiration Biopsy Reimbursement on Clinical Care of Patients with Thyroid Nodules in the United States.
    Thyroid. 2024 Oct 16. doi: 10.1089/thy.2024.0442.
    PubMed     Abstract available
    
    
    
83. ASHTON J, Morrison S, Erkanli A, Wildman-Tobriner B, et al
    Assessment of the Diagnostic Performance of a Commercially Available Artificial Intelligence Algorithm for Risk Stratification of Thyroid Nodules on Ultrasound.
    Thyroid. 2024 Oct 15. doi: 10.1089/thy.2024.0410.
    PubMed     Abstract available
    
    
    
84. MATSUMOTO Y, Kobashi Y, Yamaya Y, Sekino M, et al
    Clinicopathological Findings of 220 Pediatric, Adolescent, and Young Adult Patients with Thyroid Cancer in Fukushima Medical University Hospital.
    Thyroid. 2024 Oct 14. doi: 10.1089/thy.2024.0226.
    PubMed     Abstract available
    
    
    September 2024
85. KROPINSKA A, Ledwon A, Paliczka Cieslik E, Olczyk T, et al
    Changing Clinical Presentation of Pediatric Differentiated Thyroid Cancer in Poland: A Retrospective Cohort Study Spanning 45 Years.
    Thyroid. 2024 Sep 25. doi: 10.1089/thy.2024.0109.
    PubMed     Abstract available
    
    
    
86. KIM MJ, Won H, Kim WB, Lee EK, et al
    Comparison of Patient Reported Outcomes between Active surveillance and Immediate Lobectomy in Patients with Low-risk Papillary Thyroid Microcarcinoma: Initial Findings from the KoMPASS cohort.
    Thyroid. 2024 Sep 17. doi: 10.1089/thy.2024.0264.
    PubMed     Abstract available
    
    
    
87. ATTIA A, Touma E, Lussey-Lepoutre C, Ghander C, et al
    Consideration of Early Dynamic Risk Stratification to Guide Discharge from Oncologic Follow-up in Patients with Differentiated Thyroid Cancer.
    Thyroid. 2024 Sep 17. doi: 10.1089/thy.2024.0119.
    PubMed     Abstract available
    
    
    
88. MASTNIKOVA K, Bulanova Pekova B, Kuklikova V, Vaclavikova E, et al
    DICER1 Variants in Pediatric and Young Adult Thyroid Nodules.
    Thyroid. 2024 Sep 16. doi: 10.1089/thy.2024.0188.
    PubMed     Abstract available
    
    
    
89. VAN DE BERG DJ, Rodriguez Schaap PM, Jamaludin FS, van Santen HM, et al
    The Definition of Recurrence of Differentiated Thyroid Cancer: A Systematic Review of the Literature.
    Thyroid. 2024 Sep 16. doi: 10.1089/thy.2024.0271.
    PubMed     Abstract available
    
    
    
90. SONG Z, Wu C, Kasmirski J, Gillis A, et al
    Incidental Thyroid Nodules on Computed Tomography: A Systematic Review and Meta-analysis Examining Prevalence, Follow-up and Risk of Malignancy.
    Thyroid. 2024 Sep 16. doi: 10.1089/thy.2024.0313.
    PubMed     Abstract available
    
    
    
91. LEE JY, Lee MK, Lee JH, Kim K, et al
    Cancer risks of patients with Graves' disease who received antithyroid drugs as initial treatment: A nationwide population-based analysis.
    Thyroid. 2024 Sep 3. doi: 10.1089/thy.2024.0178.
    PubMed     Abstract available
    
    
    August 2024
92. LEE JY, Na DG, Sim JS, Sung JY, et al
    A Prospective Clinical Trial of Radiofrequency Ablation in Patients with Low-Risk Unifocal Papillary Thyroid Microcarcinoma favoring Active Surveillance over Surgery.
    Thyroid. 2024 Aug 30. doi: 10.1089/thy.2024.0098.
    PubMed     Abstract available
    
    
    
93. WANG Z, Yao Q, Bao L, Chang H, et al
    Clinicopathological Features of CCDC6-RET and NCOA4-RET Fusions in Thyroid Cancer: A Single-center Retrospective Cohort Study in a Chinese Population.
    Thyroid. 2024 Aug 30. doi: 10.1089/thy.2024.0151.
    PubMed     Abstract available
    
    
    
94. PRINZI A, van Velsen EFS, Belfiore A, Frasca F, et al
    Brain Metastasis in Differentiated Thyroid Cancer: Clinical Presentation, Diagnosis and Management.
    Thyroid. 2024 Aug 20. doi: 10.1089/thy.2024.0240.
    PubMed     Abstract available
    
    
    
95. WEN S, Wu Y, Wang JY, Ni Z, et al
    BRAFV600E/ p-ERK/ p-DRP1(Ser616) Promotes Tumor Progression and Reprogramming of Glucose Metabolism in Papillary Thyroid Cancer.
    Thyroid. 2024 Aug 20. doi: 10.1089/thy.2023.0700.
    PubMed     Abstract available
    
    
    
96. RICARTE-FILHO JC, Reichenberger ER, Hinkle K, Isaza A, et al
    TG-IGF1R: A Novel Receptor Tyrosine Kinase Fusion Oncogene in Pediatric Thyroid Cancer.
    Thyroid. 2024 Aug 6. doi: 10.1089/thy.2024.0224.
    PubMed     Abstract available
    
    
    July 2024
97. KHENG M, Manzella A, Chao JC, Laird AM, et al
    Reoperation Rates after Initial Thyroid Lobectomy for Patients with Thyroid Cancer: A National Cohort Study.
    Thyroid. 2024 Jul 25. doi: 10.1089/thy.2024.0128.
    PubMed     Abstract available
    
    
    
98. GOLDFARB M
    In the Heat of the Moment: Thermal Ablation for 'All Things Thyroid'.
    Thyroid. 2024 Jul 23. doi: 10.1089/thy.2024.0391.
    PubMed     Abstract available
    
    
    
99. PARK SI, Baek JH, Lee DH, Chung SR, et al
    Radiofrequency Ablation for the Treatment of Benign Thyroid nodules: 10-Year Experience.
    Thyroid. 2024 Jul 23. doi: 10.1089/thy.2024.0082.
    PubMed     Abstract available
    
    
    
100. SCAPPATICCIO L, Ferrazzano P, Di Martino N, Negro R, et al
     Prevalence and Management of Complications of Percutaneous Ethanol Injection for Cystic Thyroid Nodules: A Systematic Review of Literature and Meta-analysis.
     Thyroid. 2024 Jul 20. doi: 10.1089/thy.2024.0241.
     PubMed     Abstract available
     
     
     
101. ANTUNEZ AG, Saucke MC, Bushaw KJ, Chiu AS, et al
     Surgeon preference for maximizing medical care is associated with recommending more extensive surgery for low-risk thyroid cancer.
     Thyroid. 2024 Jul 20. doi: 10.1089/thy.2024.0170.
     PubMed     Abstract available
     
     
     
102. SABBAGH MF, Janovitz T, Dias-Santagata D, Siegmund SE, et al
     FGFR Alterations in Thyroid Carcinoma: A Novel Class of Primary Drivers with Significant Therapeutic Implications and Secondary Molecular Events Potentially Mediating Resistance in Thyroid Malignancy.
     Thyroid. 2024 Jul 14. doi: 10.1089/thy.2024.0216.
     PubMed     Abstract available
     
     
     
103. SZABO YAMASHITA T, Williams-Perez S, Ehsan S, Mulder MB, et al
     The Multi-institutional Medullary Thyroid Cancer Collaborative Registry (MTCCoRe): Can a rare tumor registry accurately represent the real-world patient population?
     Thyroid. 2024 Jul 10. doi: 10.1089/thy.2024.0239.
     PubMed     Abstract available
     
     
     
104. MATRONE A, Kroiss M, Gild ML, Hamidi S, et al
     Erectile dysfunction in patients treated with selpercatinib for RET altered thyroid cancer.
     Thyroid. 2024 Jul 10. doi: 10.1089/thy.2024.0129.
     PubMed     Abstract available
     
     
     June 2024
105. PERAMPALAM S, Wu K, Gild ML, Tacon L, et al
     Association between lymphocytic thyroiditis and papillary thyroid cancer harboring mutant BRAF: a systematic review and meta-analysis.
     Thyroid. 2024 Jun 28. doi: 10.1089/thy.2024.0142.
     PubMed     Abstract available
     
     
     
106. DEVON K, Tinckam K, Humar A, Madani A, et al
     Successful Deceased Donor Parathyroid Allotransplantation: A Novel Approach in a Patient with Severe Refractory Hypoparathyroidism after Thyroidectomy for Thyroid Cancer.
     Thyroid. 2024 Jun 26. doi: 10.1089/thy.2024.0115.
     PubMed     Abstract available
     
     
     
107. DIONISIO T, Mauri G
     Ultrasound Evaluation of Ablated Thyroid Nodules: An Emerging Problem.
     Thyroid. 2024 Jun 25. doi: 10.1089/thy.2024.0244.
     PubMed     Abstract available
     
     
     
108. KOTWAL A, Vance K, Hajric K, Yuil-Valdes A, et al
     Characterization of immune infiltrate along the leading edge of differentiated thyroid cancer.
     Thyroid. 2024 Jun 25. doi: 10.1089/thy.2024.0072.
     PubMed     Abstract available
     
     
     
109. GINZBERG SP, Sharpe J, Passman JE, Amjad W, et al
     Revisiting the Relationship between Tumor Size and Risk in Well-Differentiated Thyroid Cancer.
     Thyroid. 2024 Jun 15. doi: 10.1089/thy.2023.0327.
     PubMed     Abstract available
     
     
     
110. LEE Y, Alam MR, Park H, Yim K, et al
     Improved diagnostic accuracy of thyroid fine-needle aspiration cytology with artificial intelligence technology.
     Thyroid. 2024 Jun 14. doi: 10.1089/thy.2023.0384.
     PubMed     Abstract available
     
     
     May 2024
111. SCHNEIDER AB, Mihailescu DV
     Radiation Exposure and Benign Thyroid Nodules.
     Thyroid. 2024 May 27. doi: 10.1089/thy.2024.0279.
     PubMed     Abstract available
     
     
     
112. KIM CA, Baek S, Yoo J, Chung SR, et al
     Tumor Growth Kinetics Based on Initial Tumor Volume Doubling Time in Active Surveillance of Low-Risk Papillary Thyroid Carcinoma.
     Thyroid. 2024 May 17. doi: 10.1089/thy.2024.0054.
     PubMed     Abstract available
     
     
     
113. CHEN D, Carr G, Worden FP, Veenstra CM, et al
     Survival Prognostication in Patients with Differentiated Thyroid Cancer and Distant Metastases: A SEER Population-Based Study.
     Thyroid. 2024 May 17. doi: 10.1089/thy.2023.0709.
     PubMed     Abstract available
     
     
     
114. PITOIA F, Abelleira E, Roman-Gonzalez A, Danilovic DLS, et al
     Neoadjuvant Treatment of Locally Advanced Thyroid Cancer: A Preliminary Latin American Experience.
     Thyroid. 2024 May 17. doi: 10.1089/thy.2024.0090.
     PubMed     Abstract available
     
     
     
115. CAHOON EK, Grimm E, Mabuchi K, Mai JZ, et al
     Prevalence of thyroid nodules in residents of Ukraine exposed as children or adolescents to iodine-131 from the Chornobyl accident.
     Thyroid. 2024 May 17. doi: 10.1089/thy.2023.0654.
     PubMed     Abstract available
     
     
     
116. BIONDI B
     TSH Suppression in Differentiated Thyroid Cancer Patients. Still More Questions than Answers after 30 Years.
     Thyroid. 2024 May 14. doi: 10.1089/thy.2024.0232.
     PubMed    
     
     
     
117. GUBBI S, Al-Jundi M, Foerster P, Cardenas S, et al
     The Effect of Thyrotropin Suppression on Survival Outcomes in Patients with Differentiated Thyroid Cancer: A Systematic Review and Meta-analysis.
     Thyroid. 2024 May 8. doi: 10.1089/thy.2023.0711.
     PubMed     Abstract available
     
     
     
118. MACHENS A, Lorenz K, Weber F, Dralle H, et al
     Anatomic Patterns of Nodal Spread in Unilateral Papillary and Medullary Thyroid Cancer.
     Thyroid. 2024 May 8. doi: 10.1089/thy.2024.0076.
     PubMed     Abstract available
     
     
     April 2024
119. CHOI YS, Jeon MJ, Doolittle WKL, Song DE, et al
     Macrophage-induced carboxypeptidase A4 promotes the progression of anaplastic thyroid cancer.
     Thyroid. 2024 Apr 26. doi: 10.1089/thy.2023.0427.
     PubMed     Abstract available
     
     
     
120. ZHOU Y, Yang F, Zhou H, Lv S, et al
     Alginate/carboxymethyl chitosan core-shell microspheres co-loaded with docetaxel/doxorubicin reverse chemotherapy resistance in anaplastic thyroid carcinoma.
     Thyroid. 2024 Apr 25. doi: 10.1089/thy.2024.0023.
     PubMed     Abstract available
     
     
     
121. HIDALGO-ALVAREZ J, Bianco AC
     A Scholarly Dialog on Recent Trends in NIH Funding for the Thyroid Field.
     Thyroid. 2024 Apr 25. doi: 10.1089/thy.2024.0084.
     PubMed     Abstract available
     
     
     
122. TAHARA M, Takami H, Ito Y, Okamoto T, et al
     A Prospective Cohort Study Exploring the Effect of Lenvatinib Planned Drug Holidays in Treatment of Differentiated Thyroid Cancer.
     Thyroid. 2024 Apr 17. doi: 10.1089/thy.2023.0553.
     PubMed     Abstract available
     
     
     March 2024
123. WINTER J, Axelsson E, Bjorkhem-Bergman L, Ihre Lundgren C, et al
     Five-year follow-up of health-related quality of life in differentiated thyroid cancer patients treated with total thyroidectomy and radioiodine in Sweden: a nationwide prospective cohort study.
     Thyroid. 2024 Mar 25. doi: 10.1089/thy.2023.0691.
     PubMed     Abstract available
     
     
     
124. SAWKA AM, Ghai S, Rotstein L, Irish JC, et al
     Decision Regret Following the Choice of Surgery or Active Surveillance for Small, Low-Risk Papillary Thyroid Cancer: A Prospective Cohort Study.
     Thyroid. 2024 Mar 13. doi: 10.1089/thy.2023.0634.
     PubMed     Abstract available
     
     
     
125. STILLMAN M, Kuo EJ, Liou R, Almuqate A, et al
     Molecular Testing for Bethesda III Thyroid nodules: Trends in Implementation, Cytopathology Call Rates, Surgery Rates, and Malignancy Yield at a Single Institution.
     Thyroid. 2024 Mar 12. doi: 10.1089/thy.2023.0664.
     PubMed     Abstract available
     
     
     February 2024
126. JIANG YJ, Xia Y, Hu Y, Han Z, et al
     Identification of P21 (CDKN1A) Activated Kinase 4 as a susceptibility gene for Familial Non-medullary Thyroid Carcinoma.
     Thyroid. 2024 Feb 27. doi: 10.1089/thy.2023.0564.
     PubMed     Abstract available
     
     
     
127. SFREDDO HJ, Koh ES, Zhao K, Swartzwelder CE, et al
     RAS-Mutated Cytologically Indeterminate Thyroid Nodules: Prevalence of Malignancy and Behavior Under Active Surveillance.
     Thyroid. 2024 Feb 26. doi: 10.1089/thy.2023.0544.
     PubMed     Abstract available
     
     
     
128. FERNANDEZ-VELASCO P, Perez Lopez P, Torres B, Delgado E, et al
     Clinical evaluation of an Artificial Intelligence-based decision support system for the diagnosis and ACR TI-RADS classification of thyroid nodules.
     Thyroid. 2024 Feb 18. doi: 10.1089/thy.2023.0603.
     PubMed     Abstract available
     
     
     
129. HAMPTON J, Alam A, Zdenkowski N, Rowe C, et al
     Fear of Cancer Recurrence in Differentiated Thyroid Cancer Survivors - A Systematic Review.
     Thyroid. 2024 Feb 18. doi: 10.1089/thy.2023.0642.
     PubMed     Abstract available
     
     
     
130. PASCHKE R
     Why did the rapid increase of reflex molecular testing of indeterminate FNA cytologies in the USA not impact thyroidectomy rates? What is the lesson to be learned?
     Thyroid. 2024 Feb 12. doi: 10.1089/thy.2024.0042.
     PubMed     Abstract available
     
     
     
131. ESPINOSA DE YCAZA AE, Brito JP, McCoy R, Shao H, et al
     GLP-1 receptor agonists and thyroid cancer: a narrative review.
     Thyroid. 2024 Feb 12. doi: 10.1089/thy.2023.0530.
     PubMed     Abstract available
     
     
     
132. TAHARA M, Kiyota N, Imai H, Takahashi S, et al
     A phase II study of encorafenib in combination with binimetinib in patients with metastatic BRAF-mutated thyroid cancer in Japan.
     Thyroid. 2024 Feb 12. doi: 10.1089/thy.2023.0547.
     PubMed     Abstract available
     
     
     January 2024
133. BROCK P, Liyanarachchi S, Nieminen TT, Chan C, et al
     CHEK2 founder variants and thyroid cancer risk.
     Thyroid. 2024 Jan 27. doi: 10.1089/thy.2023.0529.
     PubMed     Abstract available
     
     
     
134. LIU CH, Zhao H, Lu Y, Xia Y, et al
     A long-term study comparing the quality of life and psychological status of patients with highly suspicious thyroid nodules
     Thyroid. 2024 Jan 25. doi: 10.1089/thy.2023.0478.
     PubMed     Abstract available
     
     
     
135. HUANG Y, Chan SJ, Wright JD, Kuo JH, et al
     Does the Adoption of Molecular Testing Cause Decreased Thyroidectomy Rates in a National Cohort? A Quasi-Experimental Study of High- Vs. Low-Adoption States.
     Thyroid. 2024 Jan 22. doi: 10.1089/thy.2023.0651.
     PubMed     Abstract available
     
     
     
136. YANG F, Yang M, Liu Y, Zhou C, et al
     PDLIM7 promotes tumor metastasis in papillary thyroid carcinoma via stabilizing FAK protein.
     Thyroid. 2024 Jan 20. doi: 10.1089/thy.2023.0497.
     PubMed     Abstract available
     
     
     
137. HAMIDI S, Iyer P, Dadu R, Gule-Monroe M, et al
     Checkpoint Inhibition in Addition to Dabrafenib/Trametinib for BRAF(V600E) Mutated Anaplastic Thyroid Carcinoma.
     Thyroid. 2024 Jan 16. doi: 10.1089/thy.2023.0573.
     PubMed     Abstract available
     
     
     
138. MIYAUCHI A
     Response to Xiang J. and Zhang H. re: "Active Surveillance Outcomes of Patients with Low-Risk Papillary Thyroid Microcarcinoma According to Levothyroxine Treatment Status".
     Thyroid. 2024 Jan 16. doi: 10.1089/thy.2023.0697.
     PubMed     Abstract available
     
     
     
139. XIANG J, Zhang H
     Letter to the Editor: Active Surveillance Outcomes of Patients with Low-Risk Papillary Thyroid Microcarcinoma According to Levothyroxine Treatment Status.
     Thyroid. 2024 Jan 16. doi: 10.1089/thy.2023.0605.
     PubMed     Abstract available
     
     
     
140. 
     Correction to: Factors Associated with Survival in Anaplastic Thyroid Carcinoma: A Multicenter Study from the ENDOCAN-TUTHYREF Network by Jannin et al. Thyroid 2023;33(10):1190-1200; doi: 10.1089/thy.2023.0164.
     Thyroid. 2024;34:140.
     PubMed    
     
     
     December 2023
141. TRAN TV, Schonfeld SJ, Pasqual E, Haymart MR, et al
     All-cause and cause-specific mortality among low-risk differentiated thyroid cancer survivors in the United States.
     Thyroid. 2023 Dec 27. doi: 10.1089/thy.2023.0449.
     PubMed     Abstract available
     
     
     
142. PARK SK, Ryoo JH, Kim MH, Jung JY, et al
     Association between eight autoimmune diseases and thyroid cancer: A Nationwide Cohort Study.
     Thyroid. 2023 Dec 27. doi: 10.1089/thy.2023.0353.
     PubMed     Abstract available
     
     
     
143. BERNARDI S, Rosolen V, Barbone F, Borgato S, et al
     Clinical outcomes of thermal ablation retreatment of benign thyroid nodules: A multicenter study from the Italian minimally-invasive treatments of the thyroid group.
     Thyroid. 2023 Dec 27. doi: 10.1089/thy.2023.0501.
     PubMed     Abstract available
     
     
     
144. SHIRAI YT, Hoshi N, Ward JM, Liu H, et al
     Establishment and characterization of amitrole-induced mouse thyroid adenomatous nodule-derived cell lines.
     Thyroid. 2023 Dec 27. doi: 10.1089/thy.2023.0341.
     PubMed     Abstract available
     
     
     
145. POMA AM, Macerola E, Ghossein R MD, Tallini G, et al
     Prevalence of differentiated high-grade thyroid carcinoma among well-differentiated tumors: a systematic review and meta-analysis.
     Thyroid. 2023 Dec 19. doi: 10.1089/thy.2023.0350.
     PubMed     Abstract available
     
     
     
146. TAYLOR SR, Chiu AS, Hoxha I, Saucke MC, et al
     Assessing Fear of Thyroid Cancer in the General U.S. Population: A Cross-Sectional Study.
     Thyroid. 2023 Dec 19. doi: 10.1089/thy.2023.0479.
     PubMed     Abstract available
     
     
     
147. CHENG SY, Kimura T, Doolittle WKL, Kruhlak M, et al
     Inhibition of MEK signaling attenuates cancer stem cell activity in anaplastic thyroid cancer.
     Thyroid. 2023 Dec 19. doi: 10.1089/thy.2023.0521.
     PubMed     Abstract available
     
     
     
148. HUSTON-PATERSON HH, Mao YV, Tseng CH, Kim J, et al
     Rural-urban Disparities in the Continuum of Thyroid Cancer Care: Analysis of 92,794 cases.
     Thyroid. 2023 Dec 19. doi: 10.1089/thy.2023.0357.
     PubMed     Abstract available
     
     
     
149. FEI-ZHANG D, Verma R, Arimoto R, Lawrence AS, et al
     Social Vulnerability Association with Thyroid Cancer Disparities in the United States.
     Thyroid. 2023 Dec 9. doi: 10.1089/thy.2023.0370.
     PubMed     Abstract available
     
     
     
150. HURST ZA, Liyanarachchi S, Brock P, He H, et al
     Presumed Pathogenic Germline and Somatic Variants in African American Thyroid Cancer.
     Thyroid. 2023 Dec 7. doi: 10.1089/thy.2023.0487.
     PubMed     Abstract available
     
     
     
151. CAPDEVILA J, Krajewska J, Hernando J, Robinson B, et al
     Increased progression-free survival with cabozantinib versus placebo in patients with radioiodine-refractory differentiated thyroid cancer irrespective of prior VEGFR-targeted therapy and tumor histology: a subgroup analysis of the COSMIC-311 study.
     Thyroid. 2023 Dec 7. doi: 10.1089/thy.2023.0463.
     PubMed     Abstract available
     
     
     
152. BROCK P, Sevigny M, Liyanarachchi S, Comiskey DF Jr, et al
     PDPR gene variants predisposing to papillary thyroid cancer.
     Thyroid. 2023 Dec 7. doi: 10.1089/thy.2023.0560.
     PubMed     Abstract available
     
     
     
153. CENSI S, Galuppini F, Clausi C, Battheu F, et al
     Tumor grade and molecular characteristics associated with survival in sporadic medullary thyroid carcinoma.
     Thyroid. 2023 Dec 4. doi: 10.1089/thy.2023.0482.
     PubMed     Abstract available
     
     
     
154. CAVALLO AC, Pitoia F, Roberti J, Brenzoni P, et al
     Optimizing Diagnostic Accuracy of Fine Needle Aspiration Biopsy Calcitonin Measurements in Detecting Medullary Thyroid Carcinoma.
     Thyroid. 2023 Dec 4. doi: 10.1089/thy.2023.0313.
     PubMed     Abstract available
     
     
     November 2023
155. PARK SJ, Kim M, Jeong S, Park YJ, et al
     Association Between Antibiotic Exposure and Thyroid Cancer: A Nationwide Cohort Study in South Korea.
     Thyroid. 2023 Nov 27. doi: 10.1089/thy.2023.0235.
     PubMed     Abstract available
     
     
     
156. DE KOSTER EJ, Morreau H, Bleumink GS, van Engen-van Grunsven I, et al
     Molecular diagnostics and [18F]FDG-PET/CT in indeterminate thyroid nodules: complementing techniques or waste of valuable resources?
     Thyroid. 2023 Nov 27. doi: 10.1089/thy.2023.0337.
     PubMed     Abstract available
     
     
     
157. SUBBIAH V, Hu MI, Mansfield AS, Taylor MH, et al
     Pralsetinib in Patients with Advanced/metastatic RET-altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study.
     Thyroid. 2023 Nov 27. doi: 10.1089/thy.2023.0363.
     PubMed     Abstract available
     
     
     
158. CAMPBELL DJ, Estephan LE, Sina E, Mastrolonardo EV, et al
     Evaluating ChatGPT responses on thyroid nodules for patient education.
     Thyroid. 2023 Nov 27. doi: 10.1089/thy.2023.0491.
     PubMed     Abstract available
     
     
     
159. ASSAAD S, Dov D, Park C, Davis R, et al
     A preliminary study comparing the performance of thyroid molecular tests to a deep learning algorithm in predicting malignancy in indeterminate thyroid fine needle aspiration biopsies.
     Thyroid. 2023 Nov 27. doi: 10.1089/thy.2023.0054.
     PubMed    
     
     
     
160. KENNEDY E, Zhang C, Qadadha Y, Cheng CF, et al
     Rates of Detecting Thyroid Nodules Recommended for Biopsy with Ultrasound: Are All Indications Equal?
     Thyroid. 2023 Nov 19. doi: 10.1089/thy.2023.0234.
     PubMed     Abstract available
     
     
     
161. TARASOVA VD, Tsai J, Masannat J, Hernandez-Prera J, et al
     Characterization of the thyroid cancer genomic landscape by plasma-based circulating tumor DNA next-generation sequencing.
     Thyroid. 2023 Nov 14. doi: 10.1089/thy.2023.0204.
     PubMed     Abstract available
     
     
     
162. LI X, Peng C, Liu Y, Hu Y, et al
     Modified ACR TI-RADS and Modified AI TI-RADS for Thyroid Nodules: A Multicenter Retrospective Study.
     Thyroid. 2023 Nov 11. doi: 10.1089/thy.2023.0429.
     PubMed     Abstract available
     
     
     
163. LEE I, Grice JV, Ji X, Chen Q, et al
     A Pilot Nonrandomized Controlled Trial Examining the Use of Artificial Tears on the Radioactivity of Tears after Radioactive Iodine Treatment for Thyroid Cancer.
     Thyroid. 2023 Nov 2. doi: 10.1089/thy.2023.0338.
     PubMed     Abstract available
     
     
     
164. TORO-TOBON D, Morris JC 3rd, Hilger CR, Peskey C, et al
     Clinical outcomes of radioactive iodine redifferentiation therapy in previously iodine refractory differentiated thyroid cancers.
     Thyroid. 2023 Nov 2. doi: 10.1089/thy.2023.0456.
     PubMed     Abstract available
     
     
     
165. MOOG S, Lamartina L, Bani MA, Al Ghuzlan A, et al
     Alkylating Agent-Induced High Tumor Mutational Burden in Medullary Thyroid Cancer and Response to Immune Checkpoint Inhibitors: Two Case Reports.
     Thyroid. 2023;33:1368-1373.
     PubMed     Abstract available
     
     
     October 2023
166. LI X, Li Y, Yan L, Xiao J, et al
     Sonographic Evolution and Pathologic Findings of Papillary Thyroid Cancer after Radiofrequency Ablation: a 5-Year Retrospective Cohort Study.
     Thyroid. 2023 Oct 26. doi: 10.1089/thy.2023.0415.
     PubMed     Abstract available
     
     
     
167. BACH K, Ansari P, Ansari H, Mott NM, et al
     Health-related Quality of Life in Patients with Low-risk Differentiated Thyroid Cancer: A Systematic Review Examining the Extent of Thyroidectomy.
     Thyroid. 2023 Oct 20. doi: 10.1089/thy.2023.0328.
     PubMed     Abstract available
     
     
     
168. XU B, Viswanathan K, Ahadi MS, Ahmadi S, et al
     Association of the Genomic Profile of Medullary Thyroid Carcinoma with Tumor Characteristics and Clinical Outcomes in an International Multicenter Study.
     Thyroid. 2023 Oct 16. doi: 10.1089/thy.2023.0279.
     PubMed     Abstract available
     
     
     
169. JANNIN A, Giudici F, de la Fouchardiere C, Al Ghuzlan A, et al
     Factors Associated with Survival in Anaplastic Thyroid Carcinoma: A Multicenter Study from the ENDOCAN-TUTHYREF Network.
     Thyroid. 2023;33:1190-1200.
     PubMed     Abstract available
     
     
     September 2023
170. PAPADOPOULOU A, Asvold BO, Burgess S, Kus A, et al
     Height, autoimmune thyroid disease and thyroid cancer: a Mendelian randomisation study.
     Thyroid. 2023 Sep 29. doi: 10.1089/thy.2023.0272.
     PubMed     Abstract available
     
     
     
171. STEWARDSON P, Eszlinger M, Wu J, Khalil M, et al
     Prospective Validation of ThyroSPEC Molecular Testing of Indeterminate Thyroid Nodule Cytology Following Diagnostic Pathway Optimization.
     Thyroid. 2023 Sep 24. doi: 10.1089/thy.2023.0255.
     PubMed     Abstract available
     
     
     
172. XIAO X, Chen M, Sang Y, Xue J, et al
     Methylation-mediated silencing of ATF3 promotes thyroid cancer progression by regulating prognostic genes in the MAPK and PI3K/AKT pathways.
     Thyroid. 2023 Sep 24. doi: 10.1089/thy.2023.0157.
     PubMed     Abstract available
     
     
     
173. GUPTA M, Misariu AM, Saydy N, Nichols A, et al
     A Multicentre Retrospective Study of Anaplastic Thyroid Cancer in the Era of Targeted Therapy in a Public Health Care System: Canada's Experience.
     Thyroid. 2023 Sep 19. doi: 10.1089/thy.2023.0088.
     PubMed     Abstract available
     
     
     
174. DE LEO S, D'Elia S, Grani G, Dondi F, et al
     A Prospective, Multicenter Study Examining the Relationship between Thyroid Cancer Treatment Outcomes and the Presence of Autoimmune Thyroiditis.
     Thyroid. 2023 Sep 19. doi: 10.1089/thy.2023.0052.
     PubMed     Abstract available
     
     
     
175. BALAKIROUCHENANE D, Seban R, Groussin L, Puszkiel A, et al
     Pharmacokinetics/Pharmacodynamics of dabrafenib and trametinib for redifferentiation and treatment of radioactive-iodine-resistant mutated advanced differentiated thyroid cancer.
     Thyroid. 2023 Sep 19. doi: 10.1089/thy.2023.0228.
     PubMed     Abstract available
     
     
     
176. BIONDI B MD, Pucci M, Pontieri G, Formisano P, et al
     PRELIMINARY RESULTS OF A DOUBLE-BLIND RANDOMIZED CONTROLLED TRIAL EVALUATING THE CARDIO-METABOLIC EFFECTS OF LEVOTHYROXINE AND LIOTHYRONINE COMPARED TO LEVOTHYROXINE WITH PLACEBO IN ATHYREOTIC LOW RISK THYROID CANCER PATIENTS.
     Thyroid. 2023 Sep 19. doi: 10.1089/thy.2023.0135.
     PubMed     Abstract available
     
     
     
177. GUNDA V, Ghosh C, Hu J, Zhang L, et al
     Combination BRAFV600E inhibition with the multitargeting tyrosine kinase inhibitor axitinib shows additive anticancer activity in BRAFV600E-mutant anaplastic thyroid cancer.
     Thyroid. 2023 Sep 7. doi: 10.1089/thy.2023.0201.
     PubMed     Abstract available
     
     
     
178. FAGIN JA, Nikiforov YE
     Progress in Thyroid Cancer Genomics: A 40-Year Journey.
     Thyroid. 2023 Sep 4. doi: 10.1089/thy.2023.0045.
     PubMed     Abstract available
     
     
     August 2023
179. SINCLAIR CF, Baek JH, Hands KE, Hodak SP, et al
     General principles for the safe performance, training and adoption of ablation techniques for benign thyroid nodules: An American Thyroid Association Statement.
     Thyroid. 2023 Aug 29. doi: 10.1089/thy.2023.0281.
     PubMed     Abstract available
     
     
     
180. ROSS DS
     Response to Yan et al. re "Could Radioactive Iodine be a Preferred Therapy for Graves' Hyperthyroidism Patients with Large Goiters? A Viewpoint from China.
     Thyroid. 2023 Aug 25. doi: 10.1089/thy.2023.0423.
     PubMed     Abstract available
     
     
     
181. TUTTLE RM MD
     Is there a role for levothyroxine therapy in euthyroid patients on active surveillance for papillary microcarcinomas?
     Thyroid. 2023 Aug 19. doi: 10.1089/thy.2023.0424.
     PubMed     Abstract available
     
     
     
182. SALAS-LUCIA F, Liao XH, Jiang H, Dumitrescu AM, et al
     The Relationship between Fetal THRB Genotype and Maternal Thyroid Function.
     Thyroid. 2023 Aug 19. doi: 10.1089/thy.2023.0236.
     PubMed     Abstract available
     
     
     
183. BANG JI, Park S, Kim K, Seo Y, et al
     The Diagnostic Value of F-18 FDG PET/CT in Differentiated Thyroid Cancer Patients with Elevated Thyroglobulin/Thyroglobulin Antibody Levels and Negative Iodine Scintigraphy: A Systematic Review and Meta-analysis.
     Thyroid. 2023 Aug 19. doi: 10.1089/thy.2023.0264.
     PubMed     Abstract available
     
     
     
184. YAN S, Li X, Yan B
     Letter to the Editor: Could Radioactive Iodine Be a Preferred Therapy for Graves' Hyperthyroidism Patients with Large Goiters? A Viewpoint from China.
     Thyroid. 2023 Aug 18. doi: 10.1089/thy.2023.0332.
     PubMed    
     
     
     
185. WADSLEY J, Ainsworth G, Coulson AB, Garcez K, et al
     Results of the SEL-I-METRY phase II trial on resensitisation of advanced iodine refractory differentiated thyroid cancer to radioiodine therapy.
     Thyroid. 2023 Aug 11. doi: 10.1089/thy.2022.0707.
     PubMed     Abstract available
     
     
     July 2023
186. DE LEO S, Trevisan M, Re Sarto GV, Moneta C, et al
     TUMOR LYSIS SYNDROME DURING SELPERCATINIB TREATMENT IN A PATIENT WITH MEDULLARY THYROID CANCER.
     Thyroid. 2023 Jul 18. doi: 10.1089/thy.2023.0214.
     PubMed    
     
     
     
187. SINGER S, Al-Ibraheem A, Pinto M, Iakovou I, et al
     International phase IV field study for the reliability and validity of the European Organisation for Research and Treatment of Cancer Thyroid Cancer Module EORTC QLQ-THY34.
     Thyroid. 2023 Jul 14. doi: 10.1089/thy.2023.0221.
     PubMed     Abstract available
     
     
     
188. ALI SZ, Baloch ZW, Cochand-Priollet B, Schmitt FC, et al
     The 2023 Bethesda System for Reporting Thyroid Cytopathology.
     Thyroid. 2023 Jul 8. doi: 10.1089/thy.2023.0141.
     PubMed     Abstract available
     
     
     June 2023
189. MARCZYK VR, Recamonde-Mendoza M, Maia AL, Goemann IM, et al
     Classification of Thyroid Tumors Based on DNA Methylation Patterns.
     Thyroid. 2023 Jun 30. doi: 10.1089/thy.2023.0074.
     PubMed     Abstract available
     
     
     
190. LEBOULLEUX S, Benisvy D, Taieb D, Attard M, et al
     MERAIODE: A Phase II Redifferentiation Trial with Trametinib and 131I in Metastatic Radioactive Iodine Refractory RAS Mutated Differentiated thyroid Cancer.
     Thyroid. 2023 Jun 23. doi: 10.1089/thy.2023.0240.
     PubMed     Abstract available
     
     
     
191. O'NEILL C, Carlson M, Rowe C, Fradgley E, et al
     Hearing the voices of Australian thyroid cancer survivors: qualitative thematic analysis of semi-structured interviews identifies unmet support needs.
     Thyroid. 2023 Jun 19. doi: 10.1089/thy.2023.0080.
     PubMed     Abstract available
     
     
     
192. YAMAMOTO M, Miyauchi A, Ito Y, Fujishima M, et al
     Active Surveillance Outcomes of Patients with Low-risk Papillary Thyroid Microcarcinoma According to Levothyroxine Treatment Status.
     Thyroid. 2023 Jun 13. doi: 10.1089/thy.2023.0046.
     PubMed     Abstract available
     
     
     
193. BAUDIN C, Bressand A, Buffet C, Menegaux F, et al
     Dysfunction of the salivary and lacrimal glands after radioiodine therapy for thyroid cancer: Results of the START study after 6-months of follow-up.
     Thyroid. 2023 Jun 10. doi: 10.1089/thy.2023.0090.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.